Back to User profile » Dr Mohamed Attwa

Papers published by Dr Mohamed Attwa:

Original Research

LC–MS/MS Estimation of Rociletinib Levels in Human Liver Microsomes: Application to Metabolic Stability Estimation

Attwa MW, Abdelhameed AS, Kadi AA

Drug Design, Development and Therapy 2021, 15:3915-3925

Published Date: 15 September 2021

Original Research

Characterization of Stable and Reactive Metabolites of the Anticancer Drug, Ensartinib, in Human Liver Microsomes Using LC-MS/MS: An in silico and Practical Bioactivation Approach

Abdelhameed AS, Attwa MW, Kadi AA

Drug Design, Development and Therapy 2020, 14:5259-5273

Published Date: 30 November 2020

Original Research

LC-MS/MS Estimation of the Anti-Cancer Agent Tandutinib Levels in Human Liver Microsomes: Metabolic Stability Evaluation Assay

Attwa MW, Abdelhameed AS, Al-Shakliah NS, Kadi AA

Drug Design, Development and Therapy 2020, 14:4439-4449

Published Date: 23 October 2020

Original Research

Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC–MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity Studies

Attwa MW, Kadi AA, Abdelhameed AS, Alhazmi HA

Drug Design, Development and Therapy 2020, 14:783-793

Published Date: 25 February 2020

Original Research

Metabolic Stability Assessment of Larotrectinib Using Liquid Chromatography Tandem Mass Spectrometry

Attwa MW, Kadi AA, Darwish HW

Drug Design, Development and Therapy 2020, 14:111-119

Published Date: 10 January 2020